Skip to content

A prospective, single-center, non-interventional study evaluated the effect of retzius-sparing robot-assisted laparoscopic radical prostatectomy with retrograde release of the neurovascular bundle

A prospective, single-center, non-interventional study evaluated the effect of retzius-sparing robot-assisted laparoscopic radical prostatectomy with retrograde release of the neurovascular bundle

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066350
Enrollment
Unknown
Registered
2022-12-01
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Intervention group:retzius-sparing robot-assisted laparoscopic radical prostatectomy with retrograde release of the neurovascular bundle

Sponsors

The Second Hospital of Tianjin Medical University, Tianjin, China
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: a.Patients with prostate cancer who met localized or local progression according to the grouping criteria for prognostic risk of prostate cancer b.Patients with a physical condition undergoing robotic-assisted laparoscopic surgery c.Patients who are willing to cooperate with and complete the study follow-up and related examinations d.Patients who volunteered to participate in this study and signed the informed consent in writing

Exclusion criteria

Exclusion criteria: a.Patients with advanced prostate cancer with metastases, including lymph node metastasis beyond the regional lymph nodes, bone metastasis, or have other organ metastases b.Patients whose patients or family refused to undergo robot-assisted laparoscopic surgery c.Patients who cannot tolerate surgery and have absolute contraindications to surgery d.Patients who could not complete the study follow-up program

Design outcomes

Primary

MeasureTime frame
urinary continence;postoperative PSA results;sexual function recovery;

Secondary

MeasureTime frame
learning curve;complication;

Countries

China

Contacts

Public ContactYong Wang

The Second Hospital of Tianjin Medical University, Tianjin, China

wy@tmu.edu.cn15122286696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026